Aripiprazole and Caudate nucleus

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between Aripiprazole and Caudate nucleus

Aripiprazole vs. Caudate nucleus

Aripiprazole, sold under the brand name Abilify among others, is an atypical antipsychotic. It is recommended and primarily used in the treatment of schizophrenia and bipolar disorder. Other uses include as an add-on treatment in major depressive disorder, tic disorders, and irritability associated with autism. According to a Cochrane review, evidence for the oral form in schizophrenia is not sufficient to determine effects on general functioning. Additionally, because many people dropped out of the medication trials before they were completed, the overall strength of the conclusions is low. Side effects include neuroleptic malignant syndrome, a movement disorder known as tardive dyskinesia, and high blood sugar in those with diabetes. In the elderly there is an increased risk of death. It is thus not recommended for use in those with psychosis due to dementia. It is pregnancy category C in the United States and category C in Australia, meaning there is possible evidence of harm to the fetus. It is not recommended for women who are breastfeeding. It is unclear whether it is safe or effective in people less than 18 years old. It is a partial dopamine agonist. Aripiprazole was developed by Otsuka in Japan. In the United States, Otsuka America markets it jointly with Bristol-Myers Squibb. From April 2013 to March 2014, sales of Abilify amounted to almost $6.9 billion. The caudate nucleus is one of the structures that make up the dorsal striatum, which is a component of the basal ganglia.

Akathisia

Akathisia is a movement disorder characterized by a feeling of inner restlessness and inability to stay still.

Akathisia and Aripiprazole · Akathisia and Caudate nucleus · See more »

Amphetamine

Amphetamine (contracted from) is a potent central nervous system (CNS) stimulant that is used in the treatment of attention deficit hyperactivity disorder (ADHD), narcolepsy, and obesity.

Amphetamine and Aripiprazole · Amphetamine and Caudate nucleus · See more »

Attention deficit hyperactivity disorder

Attention-deficit hyperactivity disorder (ADHD) is a mental disorder of the neurodevelopmental type.

Aripiprazole and Attention deficit hyperactivity disorder · Attention deficit hyperactivity disorder and Caudate nucleus · See more »

Obsessive–compulsive disorder

Obsessive–compulsive disorder (OCD) is a mental disorder where people feel the need to check things repeatedly, perform certain routines repeatedly (called "rituals"), or have certain thoughts repeatedly (called "obsessions").

Aripiprazole and Obsessive–compulsive disorder · Caudate nucleus and Obsessive–compulsive disorder · See more »

Paroxetine

Paroxetine, also known by trade names including Paxil and Seroxat among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is used to treat major depressive disorder, obsessive-compulsive disorder, social anxiety disorder, panic disorder, posttraumatic stress disorder, generalized anxiety disorder and premenstrual dysphoric disorder. It has also been used in the treatment of hot flashes and night sweats associated with menopause. It has a similar tolerability profile to other SSRIs. The common side effects include drowsiness, dry mouth, loss of appetite, sweating, trouble sleeping and delayed ejaculation. It may also be associated with a slightly increased risk of birth defects. The rate of withdrawal symptoms in young people may be higher with paroxetine and venlafaxine than other SSRIs and SNRIs. Several studies have associated paroxetine with suicidal thinking and behavior in children and adolescents. Marketing of the drug began in 1992 by the pharmaceutical company SmithKline Beecham, known since 2000 as GlaxoSmithKline. Generic formulations have been available since 2003 when the patent expired. The United States Department of Justice fined GlaxoSmithKline $3 billion in 2012, including a sum for withholding data on paroxetine, unlawfully promoting it for under-18s and preparing an article, following one of its clinical trials, study 329, that misleadingly reported the drug was effective in treating adolescent depression.

Aripiprazole and Paroxetine · Caudate nucleus and Paroxetine · See more »

Positron emission tomography

Positron-emission tomography (PET) is a nuclear medicine functional imaging technique that is used to observe metabolic processes in the body as an aid to the diagnosis of disease.

Aripiprazole and Positron emission tomography · Caudate nucleus and Positron emission tomography · See more »

Putamen

The putamen is a round structure located at the base of the forebrain (telencephalon).

Aripiprazole and Putamen · Caudate nucleus and Putamen · See more »

Schizophrenia

Schizophrenia is a mental disorder characterized by abnormal social behavior and failure to understand reality.

Aripiprazole and Schizophrenia · Caudate nucleus and Schizophrenia · See more »

Striatum

The striatum, or corpus striatum (also called the neostriatum and the striate nucleus) is a nucleus (a cluster of neurons) in the subcortical basal ganglia of the forebrain.

Aripiprazole and Striatum · Caudate nucleus and Striatum · See more »